Filing Details

Accession Number:
0001567619-20-015709
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-08-18 17:09:10
Reporting Period:
2020-08-14
Accepted Time:
2020-08-18 17:09:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
874716 Idexx Laboratories Inc IDXX In Vitro & In Vivo Diagnostic Substances (2835) 010393723
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1403694 L. Bruce Claflin C/O Idexx Laboratories, Inc.
One Idexx Drive
Westbrook ME 04092
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-08-14 1,111 $378.08 304 No 4 S Direct
Common Stock Acquisiton 2020-08-17 5,629 $70.54 5,933 No 4 M Direct
Common Stock Disposition 2020-08-18 5,629 $385.11 304 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right-to-buy) Disposition 2020-08-17 5,629 $0.00 5,629 $70.54
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2025-08-31 No 4 M Direct
Footnotes
  1. Represents the weighted average price of the shares sold ranging from a low of $384.90 to a high of $385.765 per share. The undersigned undertakes, upon a request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
  2. Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vested in one installment on the date of the 2016 annual meeting of shareholders.
  3. Not applicable.